Cite
HARVARD Citation
Song, Y. et al. (n.d.). 791 A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with relapsed or refractory classic hodgkin lymphoma (cHL). Journal for immunotherapy of cancer. p. A840. [Online].